Due to high rates of student loan delinquency, nearly 60 percent of America’s HBCUs could lose access to federal aid.

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...